Pro Medicus (ASX:PME) subsidiary secures contract with UW Medicine


  • Pro Medicus’ (PME) subsidiary Visage Imaging signs $25 million, seven-year contract with University of Washington’s UW Medicine
  • The company will implement its cloud-engineered Visage 7 platform across UW Medicine’s network, as well as its workflow and archive models
  • Pro Medicus CEO Dr Sam Hupert says the new contract adds to its growing portfolio
  • Preparations for the rollout have commenced, with ‘go-lives’ targeted for the middle of 2023
  • Pro Medicus shares were up 0.11 per cent, trading at $61.07 at 11:20 am AEDT

Pro Medicus’ (PME) subsidiary, Visage Imaging, has signed a $25 million, seven-year contract with the University of Washington’s UW Medicine.

UW Medicine has multiple campuses throughout Seattle, employing 29,000 healthcare professionals, researchers and educators.

The deal will see the company apply its cloud-engineered Visage 7 Enterprise Imaging Platform (Visage 7), but also offer its workflow and archive models across the network.

Pro Medicus CEO Dr Sam Hupert said acquiring the latest tier one academic health system adds to its growing list of clients.

“UW Medicine joins our growing list of tier one academic clients and will provide us with a strong presence in the Northwest region of the United States,” he said.

“With its highly regarded University of Washington School of Medicine, it has the added benefit of exposing Visage to an ever-increasing number of doctors for tomorrow.”

The adoption of fully cloud-based solutions, such as UW Medicine’s efforts, have become increasingly popular within the North American healthcare IT market.

Preparations for the rollout have started, with aims of ‘go-lives’ targeted for the middle of 2023.

Pro Medicus shares were up 0.11 per cent, trading at $61.07 at 11:20 am AEDT.


arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.